Sort
30,917 grants matching “tumor microenvironment”
NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancer
$354,698Jennifer D Wu · Northwestern University At Chicago · R01 · FY2017 · CA
NKG2D superagonist co-stimulation to enhance adaptive immunotherapy of cancer
$354,698Jennifer D Wu · Northwestern University At Chicago · R01 · FY2018 · CA
Subclonal p27 Loss and Altered Tumor Immune Microenvironment as a Driver of Fatal Prostate Cancer
$354,658Karen Sandell Sfanos · Johns Hopkins University · R01 · FY2025 · CA
Project 3: Hedgehog Inhibition to Enhance Response to ICI Therapy
$354,574Ronald J Buckanovich · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · CA
Project-002
$354,566Kunle O Odunsi · University Of Chicago · P30 · FY2023 · CA
Novel targeted chemo/immunotherapy approach for localized and metastatic CaP
$354,563Mohammad Saleem Bhat · University Of Minnesota · R01 · FY2017 · CA
Development of a targeted delivery platform for checkpoint inhibitors
$354,563Kun Cheng · University Of Missouri Kansas City · R01 · FY2018 · CA
Cytokine- and Satellite Cell-mediated Muscle Disease Promotion
$354,563Charles Keller · Children'S Cancer Therapy Develop/Inst · R01 · FY2015 · CA
Osteocytes in prostate cancer bone metastasis
$354,563Evan Todd Keller · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
$354,563Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2025 · CA
Osteocytes in prostate cancer bone metastasis
$354,563Evan Todd Keller · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Roles of neutrophils in c-Met mediated breast cancer brain metastases
$354,563Fei Xing · Wake Forest University Health Sciences · R37 · FY2022 · CA
Development of a targeted delivery platform for checkpoint inhibitors
$354,563Kun Cheng · University Of Missouri Kansas City · R01 · FY2021 · CA
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$354,563Jing Yang · University Of California, San Diego · R01 · FY2015 · CA
Osteocytes in prostate cancer bone metastasis
$354,563Evan Todd Keller · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Roles of neutrophils in c-Met mediated breast cancer brain metastases
$354,563Fei Xing · Wake Forest University Health Sciences · R37 · FY2021 · CA
Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma
$354,563Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2021 · CA
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$354,563Jing Yang · University Of California, San Diego · R01 · FY2016 · CA
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
$354,563Jing Yang · University Of California, San Diego · R01 · FY2017 · CA
Roles of neutrophils in c-Met mediated breast cancer brain metastases
$354,563Fei Xing · Wake Forest University Health Sciences · R37 · FY2020 · CA
Regulation of Urinary Bladder Carcinogenesis and Progression by SPARC
$354,563Neveen Said · Wake Forest University Health Sciences · R01 · FY2016 · CA
Regulation of Urinary Bladder Carcinogenesis and Progression by SPARC
$354,563Neveen Said · Wake Forest University Health Sciences · R01 · FY2018 · CA
Regulation of Urinary Bladder Carcinogenesis and Progression by SPARC
$354,563Neveen Said · Wake Forest University Health Sciences · R01 · FY2017 · CA
P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy
$354,563Yong Lu · Wake Forest University Health Sciences · R37 · FY2020 · CA
Roles of neutrophils in c-Met mediated breast cancer brain metastases
$354,563Fei Xing · Wake Forest University Health Sciences · R37 · FY2018 · CA